Suppression of Neuroinflammation and Composition and Method Therefore

    公开(公告)号:US20230117374A1

    公开(公告)日:2023-04-20

    申请号:US17915751

    申请日:2021-03-31

    申请人: Kyoto University

    摘要: A pharmaceutical composition for suppressing neuro-inflammation; a pharmaceutical composition for assisting transplantation of neuron precursor cells, pluripotent stem cells, and/or neurons; a pharmaceutical composition for promoting the stabilization of Nrf2 protein in glial cells; a pharmaceutical composition for protecting nerve cells from neuro-inflammation are provided. Provided is a pharmaceutical composition containing, as an active ingredient, a compound having an inhibiting ability against phosphorylation activity of DYRK1A protein, or a pharmaceutically acceptable salt of the compound.

    COMPOUND AND RADIOACTIVE LABELING COMPOUND

    公开(公告)号:US20230112418A1

    公开(公告)日:2023-04-13

    申请号:US17904792

    申请日:2021-03-04

    摘要: In a compound of the present invention, in a macroscopic view of a chemical structure thereof, a chelating moiety is located at the center of the structure, an atomic group containing an albumin binding moiety binds to one side of the chelating moiety, and an atomic group containing a target molecule binding moiety binds to the other side of the chelating moiety. The chelating moiety is also preferably DOTA or a derivative thereof. The target molecule binding moiety preferably has a structure to bind to a target molecule expressed in a cancer tissue. The present invention also provides a radioactive labeled compound in which the compound is coordinated to a radioactive metal ion.

    METHOD OF PRODUCING HYDROGEN
    4.
    发明申请

    公开(公告)号:US20230098199A1

    公开(公告)日:2023-03-30

    申请号:US17801530

    申请日:2020-09-29

    IPC分类号: C01B3/22 B01J31/22

    摘要: Provided is a method of generating hydrogen efficiently using a renewable resource as a raw material.
    A method of producing hydrogen according to the present disclosure is a method in which hydrogen is generated from a saccharide in the presence of a solvent and the following catalyst: catalyst which contains at least one metal element selected from the metal elements in Groups 8, 9, and 10. The catalyst is preferably a complex or salt of the metal element, and particularly preferably a complex including the at least one metal element selected from the metal elements in Groups 8, 9, and 10 and at least one ligand selected from pentamethylcyclopentadienyl, cyclopentadienyl, p-cymene, and 1,5-cyclooctadiene.
    As the solvent, it is preferable to use at least one selected from an organic acid and an ionic liquid.
    The saccharide may be a lignin-saccharide complex, and is preferably cellulose.

    METHOD FOR PRODUCING SUGAR ANHYDRIDE AND SACCHARIDE

    公开(公告)号:US20230067889A1

    公开(公告)日:2023-03-02

    申请号:US17797489

    申请日:2021-02-26

    IPC分类号: C07H3/10 C07H1/00 C13K1/02

    摘要: A method for producing a sugar anhydride, said method comprising: (1) a step for conducting a first heat treatment by heating a polysaccharide having a reducing end at 130-350° C. in the presence of an alcohol compound having 1-10 carbon atoms and not having an acetal structure; (2) a step for conducting a second heat treatment by heating the polysaccharide having been heated in the first heat treatment and thus thermally decomposing the polysaccharide to thereby give a gaseous sugar anhydride, without forming a char or with forming a filmy char, and without generating carbon monoxide or with regulating the generation amount of carbon monoxide, if any, to not more than 5 parts by mass per 100 parts by mass of the absolute dry mass of the polysaccharide; and (3) a collection step for cooling the gaseous sugar anhydride to a temperature equal to or lower than the boiling point thereof and then collecting the same. According to this method, a sugar anhydride can be easily produced at a high yield.

    MAGNETIC FIELD MEASUREMENT APPARATUS AND MAGNETIC FIELD MEASUREMENT METHOD

    公开(公告)号:US20230051777A1

    公开(公告)日:2023-02-16

    申请号:US17794124

    申请日:2021-02-18

    IPC分类号: G01R33/24

    摘要: A magnetic resonance member 1 includes a crystal structure and is capable of electron spin quantum operations with microwaves of different frequencies corresponding to arrangement orientations of a vacancy and an impurity in a crystal lattice. A magnetic field transmission unit 4 senses a measurement target magnetic field at plural measurement positions different from each other, and applies application magnetic fields corresponding to the measurement target magnetic field sensed at the plural measurement positions to the magnetic resonance member 1 along respective different directions corresponding to the aforementioned arrangement orientations. A measurement control unit 21 controls a high frequency power supply 12, and determines detection values detected by a detecting device (an irradiating device 5 and a light receiving device 6) of the physical phenomena corresponding to the plural measurement positions. A calculation unit 22 calculates the measurement target magnetic field at the plural measurement positions on the basis of the detection values.

    Diagnostic agent and medicine comprising ADAMTS13 as main ingredient

    公开(公告)号:US11567080B2

    公开(公告)日:2023-01-31

    申请号:US16066111

    申请日:2017-01-06

    摘要: New use of ADAMTS13 in the clinical filed is provided. The use of ADAMTS13 as a biomarker for monitoring the onset of liver damage, hepatic ischemia/reperfusion injury or the liver function after liver transplantation: a method of testing liver damage, a method of testing hepatic ischemia/reperfusion injury, or a method of testing the liver function after liver transplantation, each of the methods comprising measuring or monitoring the ADAMTS13 activity in a sample from a mammal; an agent for treating diseases selected from the group consisting of liver damage, hepatic ischemia/reperfusion injury and hepatic dysfunction after liver transplantation, which comprises ADAMTS13 or a mutant of ADAMTS13 as an effective ingredient.